A detailed history of Ironwood Investment Counsel, LLC transactions in Renalytix PLC stock. As of the latest transaction made, Ironwood Investment Counsel, LLC holds 12,000 shares of RNLX stock, worth $1,800. This represents 0.0% of its overall portfolio holdings.

Number of Shares
12,000
Previous 12,000 -0.0%
Holding current value
$1,800
Previous $2,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023

BUY
$1.51 - $4.01 $18,120 - $48,120
12,000 New
12,000 $19,000

Others Institutions Holding RNLX

About Renalytix plc


  • Ticker RNLX
  • Exchange OTC
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 37,445,900
  • Market Cap $5.62M
  • Description
  • Renalytix Plc develops artificial intelligence-enabled in vitro diagnostic solutions for kidney diseases. The company offers KidneyIntelX, a diagnostic platform that employs an artificial intelligence-enabled algorithm that combines various data inputs, including validated blood-based biomarkers, inherited genetics and personalized patient data ...
More about RNLX
Track This Portfolio

Track Ironwood Investment Counsel, LLC Portfolio

Follow Ironwood Investment Counsel, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ironwood Investment Counsel, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ironwood Investment Counsel, LLC with notifications on news.